ShaMaran Announces Shareholder Approval for Primary Listing in Oslo and Corporate Continuance to Bermuda

Shareholders approved the company's continuance from Canada to Bermuda and the delisting from the TSX Venture Exchange at the March 10, 2026 special meeting. ShaMaran plans to seek a primary listing on Euronext Growth Oslo and retain a secondary listing on Nasdaq First North, shifting legal domicile and targeting greater access to European investors. The action is a corporate re-domiciliation with potential implications for trading liquidity and regulatory jurisdiction but does not directly change operational fundamentals.

Analysis

Shifting primary domicile/listing to a European growth venue typically swaps a North American retail/passive shareholder base for a concentrated, sector-savvy Nordic institutional pool. That often compresses the liquidity tail but increases the probability of analyst coverage and strategic investors within 6–12 months, producing a potential multiple re-rating in the 20–50% range if coverage and inclusion in local growth/energy lists occur.

The mechanical effects are immediate and quantifiable: forced passive outflows from Canadian TSXV-tracking vehicles (likely 5–15% of free float depending on index eligibility) create short-term price pressure, while the new venue initially suffers wider spreads and off-exchange fills: expect bid/ask blowouts equivalent to 200–600 basis points in realized transaction cost for the first 30–90 trading days. That combination creates a time-limited arbitrage window between venues and a high-volatility regime ideal for market-makers and event-driven funds.

Corporate and strategic optionality increases with a Bermuda domicile — easier capital returns, simplified cross-border M&A mechanics, and fewer domestic regulatory frictions for certain corporate actions. These are positive for long-term value but raise tail risks: governance scrutiny, potential shareholder litigation during the transition, and the possibility that Oslo-specialist investors fail to materialize, leaving liquidity degraded for quarters. Key catalysts to watch are EGO index inclusion, formal analyst coverage, and any announced buyback/dividend policy within 3–12 months.

Key Decisions for Investors

• Accumulate SNM (ticker: SNM) during the first 30 trading days post-primary Oslo listing — target 30–40% upside over 6–12 months if analyst coverage and EGO index inclusion occur; use a 15% stop-loss to limit execution/liquidity risk.
• Event-arbitrage pair: set up a 1:1 long/short between the cheaper venue and the richer venue of SNM across listings during the initial 60 days (buy the weaker listing, short the stronger) — target capture of 5–15% over 1–8 weeks; size small (<3% NAV) because execution costs and spread risk can exceed moves.
• Protective hedge: buy 3–6 month OTM puts on SNM (or a put spread if liquidity limited) sized to cover 20–30% of long exposure to cap tail risk from litigation/regulatory shocks; cost is insurance for a regime with elevated short-term trading costs and event risk.